The investigation has been approved by authorities in all three countries.
Pressure ulcers belong to the group of hard-to-heal wounds and cause much suffering and high costs worldwide. Studies show that pressure ulcers affect as many as over 10 (6-27) percent of all hospitalised patients in
Ref:
THIS IS CHLORASOLV
ChloraSolv is a debriding gel, based on a unique hypochlorite technology, which is used with very good effect on leg ulcers and diabetic foot ulcers. The gel allows the gentle removal of devitalised tissue and promotes natural wound healing.1 ChloraSolv does not damage healthy tissue and is well tolerated by the patient.
- Eliasson, B., Fagerdahl, A.M., Jönsson, A., Apelqvist, J. Debriding effect of amino acid-buffered hypochlorite on hard-to-heal wounds covered by devitalized tissue: pilot study.
Journal of Wound Care (June 2021 ) 30(6):455-464.
TRADING PLACE AND CERTIFIED ADVISER:
FOR MORE INFORMATION, PLEASE CONTACT:
Roland Frösing, acting CEO,
E-mail: roland.frosing@rlsglobal.se
Phone: +46 723 20 61 00
ABOUT
RLS's long-term vision is to be a leading research-driven platform company in wound care. The ambition is to expand into new indications through new research and development projects in areas such as wound care and dermatology. To maximize market presence, RLS works with partners to commercialize products globally. RLS is convinced that the company's platform technology and its unique features will help many patients around the world. Read more at rls.global
https://news.cision.com/rls-global-ab/r/first-patient-included-in-new-clinical-investigation-on-pressure-ulcers,c3830134
(c) 2023 Cision. All rights reserved., source